CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Michael Pfreundschuh(Universitätsklinikum des Saarlandes), Evelyn Kuhnt(Leipzig University), Lorenz Trümper(University of Göttingen), Anders Österborg(Karolinska University Hospital), Marek Trněný(General University Hospital in Prague), Lois E. Shepherd(Queen's University), Devinder Gill(Princess Alexandra Hospital), Jan Walewski, Ruth Pettengell(St George's, University of London), Ulrich Jaeger(Graz University Hospital), Pier Luigi Zinzani(Istituto di Ematologia di Bologna), Ofer Shpilberg(Rabin Medical Center), Stein Kvaløy(Norwegian Cancer Society), Peter de Nully Brown(Rigshospitalet), Rolf A. Stahel(University Hospital of Zurich), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Armando López‐Guillermo, Viola Poeschel(Universitätsklinikum des Saarlandes), Sandra Graß(Universitätsklinikum des Saarlandes), Markus Loeffler(Leipzig University), Niels Murawski(Universitätsklinikum des Saarlandes)
Cited by 810
Abstract
Related Papers
No related papers found
Powered by citation graph analysis